The ideal candidate has undergone bariatric surgery at least one year prior, maintains a stable weight (even if higher than goal), demonstrates renewed appetite or eating behavior challenges, and has no contraindications like unresolved nutritional deficiencies
Hormonal effects related to IGF-1 and androgen sensitivity may play a role
Liraglutide suppresses obesity and induces brown fat-like phenotype via soluble guanylyl cyclase mediated pathway in vivo andin vitro
What Some Of The Evidence Shows So Far To date, there are no randomised or prospective studies testing GLP-1 cycling for weight maintenance or long term management
Ratio Improvement: Despite absolute muscle loss, the STEP 1 trial showed that the proportion of lean mass relative to total body weight actually increased
Food reduces that number even further, potentially cutting absorption by more than 50%